FindTrial
Sign In

The investigation on the prevention and treatment by drug with Acute Moutain Sickness

Prevention and treatment on the Acute Mountain Sickness by drug: a Random, Double-blind, Placebo-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002219
Enrollment
Unknown
Registered
2012-06-01
Start date
2011-05-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute mountain sickness

Interventions

Drug A treatment:taking oral drug A
Drug B treatment:taking oral drug B
Drug C treatment:taking oral drug C
Drug D treatment:taking oral drug D
Drug E treatment:taking oral drug E
positive control group:taking acetazolamide
negative control group:taking placebo

Sponsors

Institute of Cardiovascular Diseases of PLA, Xinqiao Hospital, Third Military Medical University, Chongqing, China,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Healthy adults rushing into plateau,with normal hepatorenal function, and without organic disease, aged from 18 to 60; 2. Patients diagnosed by AMS criteria.

Exclusion criteria

Exclusion criteria: High altitude exposure history within past 6 months; Patients with psychological or neurological disorder; Patients with bad comp1iance.

Design outcomes

Primary

MeasureTime frame
blood pressure;oxygen saturation;Heart Rate;UCG;ECG;blood biochemistry;other;—

Countries

China

Contacts

Public ContactHuang Lan
huanglan260@yahoo.com.cn+86 13808398102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026